Syngene International

Early development decisions set the long-term trajectory. Great perspectives at the TIDES USA Conference on building scalable, future-ready peptide and oligonucleotide programs. Always valuable to learn from peers facing similar biopharma challenges. #Peptides #Oligos #TIDES

AI in small-molecule discovery isn’t just about going faster. It’s also about choosing better earlier, spotting risk sooner, and connecting data with experiments that learn. Read more: syngeneintl.com/resources/blog… #DrugDiscovery #Syngene

Two days into PEGS Boston 2026 and the conversations are energising. Real talk on antibody discovery, developability, and building biologics with the end in mind. 📍Booth #517 | Meet our team #PEGSBoston #Biologics #Syngene

Dr. Azizul chaired a technical session across catalysis, organic synthesis and medicinal chemistry at #CiS2026 at IIT (ISM) Dhanbad, underscoring how stronger industry–academia collaboration will shape the future of science. #IndustryAcademia #Syngene

Performance excellence is built every day, not announced overnight. Syngene wins the IMC Ramkrishna Bajaj National Quality Award 2025 for Manufacturing, a testament to ownership, governance maturity, and customer-first execution. #PerformanceExcellence #IMCRBNQA #Syngene

Syngene is hiring a Process Engineering Specialist in Bangalore. Work on process development, scale-up, and tech transfer in a CDMO environment. If you're a Process Engineer ready to drive manufacturing excellence, apply now: lnkd.in/g7eq9irF #SyngeneIsHiring #Pharma

A scientist’s career is shaped by great science, mentoring and timely guidance. The Catalyst Series supports early‑career researchers in building confidence, ownership and an adaptive mindset for a fast‑changing drug discovery and CRDMO landscape. #ScientificCareers #Syngene

Expanding our Antibody‑Drug Conjugate (ADC) capabilities. Our new ADC Bioconjugation Lab strengthens in‑house science from early discovery to bioconjugation. A proud step forward as we build next‑generation capabilities. #ADC #DrugDiscovery #Bioconjugation

Where is drug discovery headed next? On May 6 at IIT-Delhi, Dr. Nikhil Jain will dive into next‑gen pipelines, hyper‑inflammation, and precision tools like antibody‑drug conjugates (ADCs) and degrader antibody conjugates (DACs). #DrugDiscovery #EmergingScience #Immunology

Great conversations, real peptide challenges, and shared learning at the Peptide‑Based Therapeutics Summit 2026. From SPPS to purification, the focus stayed on quality and confidence. #PeptideTherapeutics #Syngene

Pleased to announce the appointment of Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO at Syngene, effective 1 May 2026. As EC members, they bring global experience to strengthen our people agenda & commercial strategy for the next phase of growth. #Leadership #Biopharma

Rooted in sustainability, Syngene’s Mangaluru campus marked World Earth Day 2026 by planting trees, nurturing saplings & expanding green spaces. Aligned with Our Power, Our Planet, this reflects daily responsibility guided by EHSS and ESG priorities. #WorldEarthDay #PlantTrees

As programs scale, execution becomes a strategic asset. Experience across development and commercial manufacturing helps manage complexity without slowing decisions. Meet Syngene at #BIOInternational2026, booth 4907, San Diego. Let’s talk long‑term execution. #Biopharma

At #TheGrowthSummit2026, leaders shared candid views on an industry in transition, AI as a force multiplier, and what growth really means. From sharp insights to culture-led learning, it was a moment to Reflect, Analyse and Act. #Syngene #Growth #Culture

BioProcess International Europe 2026 started yesterday and we are already deep into Biologics conversations. Find Syngene at Booth #312 to talk integrated CDMO support, from cell line to GMP manufacturing. #BPIEurope #Biologics

Better first‑in‑human decisions start with better PK insight. Catch our DMPK Unravelled webinar on PBPK modelling and dose prediction, now on demand. Watch now: syngeneintl.com/resources/webi… #PBPK #DMPK

When biologics move fast, manufacturing has to move smarter. Our integrated U.S.-India CDMO platform helps innovators go from cell line to GMP with confidence. Meet us at BioProcess International Europe. #Biologics #Bioprocessing #CDMO #mAbs #Syngene

Legacy chemistry meets modern scale. Real progress. At #CPHIJapan, Yogesh Shinde showed how classic reactions like Hantzsch thiazole still power modern medicines with smart, sustainable scale‑up. Let's talk! 📍Booth 1G‑36 #ComplexChemistry #CRDMO #Syngene

Sustainability at Syngene is about real impact. ~380K kg CO₂e reduced annually, 64% lower freshwater use, and far less waste across our labs. That’s science with responsibility built in. #EarthDay #Sustainability #Syngene

From drug substance to drug product, is your pipeline truly connected? Discover Syngene’s fully integrated CRDMO model linking discovery, development, scale‑up, and manufacturing end to end. Meet us from June 22–25 at #BIOInternational 📍Booth 4907, San Diego #Pharma #SanDiego